Instalab

Egg White (Gal d 4) IgE Test Blood

Get a closer look at how your immune system reads one specific egg white protein, beyond a single yes-or-no allergy answer.

Should you take a Egg White (Gal d 4) IgE test?

This test is most useful if any of these apply to you.

Mapping Your Child's Egg Allergy
If your child reacts to eggs, this adds one piece to a component-by-component map of which egg proteins their immune system targets.
Wondering Why Baked Egg Is Fine but Scrambled Is Not
If you tolerate egg in muffins but react to runny yolks, component testing can help explain which proteins are driving the difference.
Tracking Egg Allergy Over Time
If you have a known egg allergy, serial component IgE testing can show whether you are trending toward tolerance and ready for a supervised challenge.
Already Diagnosed with Multiple Food Allergies
If you carry several food allergies, a detailed component profile helps your allergist build a more precise picture of your immune reactivity.

About Egg White (Gal d 4) IgE

If you have ever wondered why one person breaks out in hives from a bite of scrambled egg while another tolerates muffins made with the same eggs, the answer often lies in which specific egg proteins your immune system reacts to. Eggs contain several distinct allergens, and your body can be sensitized to one, some, or all of them. This test zooms in on a single one of those proteins.

Gal d 4 IgE measures the antibodies your body has produced against lysozyme, a minor protein that makes up about 3.4% of egg white. It is one piece of a larger picture, and on its own it carries less diagnostic weight than other egg components. Knowing your level adds nuance to a broader egg allergy workup rather than serving as a standalone verdict.

What This Test Actually Measures

Egg white contains four main proteins your immune system can react to: ovomucoid (Gal d 1, about 11%), ovalbumin (Gal d 2, about 54%), conalbumin or ovotransferrin (Gal d 3, about 12%), and lysozyme (Gal d 4, about 3.4%). This test counts the IgE antibodies in your blood that recognize Gal d 4 specifically. IgE is the antibody class that drives immediate allergic reactions by binding to immune cells called mast cells and basophils, which release histamine when triggered.

Component testing like this is part of what allergists call component-resolved diagnostics. Instead of measuring antibodies to a whole crushed-egg-white mixture, it looks at your reactivity to one purified protein at a time. The advantage of this approach is precision. The catch with Gal d 4 specifically is that its diagnostic performance is weaker than the other egg components.

Where Gal d 4 Fits in the Egg Allergy Picture

Among the egg white components, ovomucoid (Gal d 1) is the strongest single predictor of clinical egg allergy. It survives cooking, so people with high Gal d 1 IgE often react even to baked goods made with egg. Gal d 4 IgE, by contrast, has not been shown to identify a unique clinically important pattern beyond what whole egg white and Gal d 1 testing already capture.

In a Finnish study of children undergoing supervised egg challenges, researchers compared how well each marker predicted who would react to heated egg. The general performance ranking is captured below.

MarkerRelative Discrimination of Heated Egg ReactivityInterpretation
Gal d 1 (ovomucoid)StrongestThe most useful single marker
Whole egg whiteStrongGood overall discriminator
Gal d 2 (ovalbumin)ModerateHelpful as part of a panel
Gal d 3 (conalbumin)WeakerLimited standalone value
Gal d 4 (lysozyme)WeakestAmong the weakest of the egg components tested

Source: Palosuo et al., Pediatric Allergy and Immunology, 2018. This ranking captures how reliably each marker separated children who reacted to heated egg from those who tolerated it.

What this means for you: a Gal d 4 IgE result is best read as one input in a panel, not as a standalone verdict. If you are trying to understand egg reactions, your Gal d 1 and whole egg white IgE will carry more diagnostic weight.

Egg Allergy and What an Elevated Result Suggests

The main condition tied to elevated egg-specific IgE is IgE-mediated egg allergy, which can range from mild skin reactions to anaphylaxis. An elevated Gal d 4 IgE specifically tells you that your immune system has produced antibodies against the lysozyme protein in egg white. It is a signal of sensitization, not proof that you will react clinically. Many sensitized people, especially children, never develop symptoms or tolerate baked egg without issue.

In a large Australian cohort of children, sensitization to multiple egg components was linked to persistent egg allergy. The more components your immune system recognized (Gal d 1 through Gal d 5), the more likely the allergy was to persist over time. Gal d 4 contributes to that broader pattern but did not stand out as uniquely predictive on its own.

Why a Single Reading Is Not the Whole Story

IgE results, including Gal d 4, are probabilistic, not absolute. A Korean study of children with suspected egg allergy found that no single egg white component, including Gal d 4, reliably predicted whether a child would actually react during a supervised food challenge. Sensitivity and specificity at the usual decision points were low. The gold standard for confirming or ruling out egg allergy remains a supervised oral food challenge, where you eat measured amounts of egg under medical observation.

This is why allergists rarely order Gal d 4 alone. It is most useful as part of a component-resolved panel that includes whole egg white, Gal d 1, and often other components, interpreted alongside your clinical history.

Tracking Your Trend Over Time

Egg allergy is one of the most likely childhood food allergies to resolve. Falling egg white IgE over months and years is associated with developing tolerance, and serial measurements help time when a supervised challenge is likely to succeed. The specific trajectory of Gal d 4 has been studied less than whole egg white or Gal d 1, but it tends to move in parallel with the broader egg sensitization profile.

If you or your child has known egg sensitization, retesting roughly every 6 to 12 months is reasonable while levels are changing. If you are starting an intervention like oral immunotherapy under specialist supervision, more frequent testing may be guided by your allergist. A single number tells you where you are today. A trend tells you where you are headed.

When Results Can Be Misleading

A few factors can distort a single IgE reading. The most important is treatment with anti-IgE biologics, the best known of which is omalizumab. These drugs bind circulating IgE and form longer-lasting complexes that standard assays cannot distinguish from free, active IgE. Total IgE can rise substantially during treatment even as symptoms improve. If you are on omalizumab or a similar biologic, your specific IgE results may not reflect your real-world allergic reactivity.

Different lab platforms (such as ImmunoCAP versus 3gAllergy) can also give slightly different numbers for the same blood sample. When tracking your trend, stick with the same lab when possible so the values are directly comparable.

What to Do With an Unexpected Result

An isolated elevated Gal d 4 IgE without symptoms is not, on its own, a reason to start avoiding eggs. The next step is to look at the full picture. Order or compare with whole egg white IgE and especially Gal d 1 (ovomucoid) IgE, which carries far more diagnostic weight. If your clinical history includes immediate reactions after eating egg, talk to an allergist about whether a supervised oral food challenge is appropriate to confirm or rule out true clinical allergy.

If multiple egg components are elevated and you have had reactions, an allergist can help map out whether you tolerate baked egg, when to consider oral immunotherapy, and how to monitor your trend toward potential tolerance. A low or undetectable Gal d 4 IgE in someone with low overall egg IgE is reassuring but does not, by itself, rule out egg allergy if your history says otherwise.

What Moves This Biomarker

Evidence-backed interventions that affect your Egg White (Gal d 4) IgE level

Increase
Omalizumab (an anti-IgE biologic)
Omalizumab binds circulating IgE and forms longer-lived complexes that standard lab assays cannot tell apart from free, biologically active IgE. The result is that measured total and specific IgE rise during treatment even as allergic symptoms improve. In published trials, symptoms have improved despite increases in measured IgE. If you are on omalizumab, a higher Gal d 4 IgE number does not mean your allergy is worsening; the assay simply cannot distinguish bound from free antibody.
MedicationStrong Evidence
Decrease
Oral immunotherapy for egg allergy (supervised escalating doses of egg)
Long-term supervised egg oral immunotherapy can lower egg-specific IgE and raise protective IgG4 antibodies, shifting your immune profile toward tolerance. In a study of children who continued egg oral immunotherapy, those treated showed declines in egg white and ovomucoid IgE alongside clinical desensitization and, in some, sustained unresponsiveness. The effect on Gal d 4 IgE specifically tracks with the broader egg component shift, though it was not isolated in published outcome data.
MedicationModerate Evidence
Decrease
Time and natural resolution of egg allergy in childhood
Egg allergy resolves in many children as the immune system matures, and falling egg white IgE over months to years is associated with developing tolerance. In one Spanish cohort of children under age 2 with egg allergy, the majority developed tolerance over several years of follow-up. Component IgE including Gal d 4 generally tracks downward with the broader egg sensitization profile during this process, though the specific Gal d 4 trajectory has been studied less than whole egg white or Gal d 1.
LifestyleModerate Evidence

Frequently Asked Questions

References

12 studies
  1. Palosuo K, Kukkonen a, Pelkonen a, Mäkelä MPediatric Allergy and Immunology2018
  2. Min T, Jeon YH, Yang H, Pyun BAllergy, Asthma & Immunology Research2013
  3. Dang T, Peters R, Koplin J, Dharmage S, Gurrin L, Ponsonby a, Martino D, Neeland M, Tang M, Allen KAllergy2018
  4. Riggioni C, Ricci C, Moya B, Wong DSH, Van Goor E, Bartha I, Buyuktiryaki B, Giovannini M, Jayasinghe S, Jaumdally H, Marques-mejias a, Piletta-zanin a, Berbenyuk a, Andreeva M, Levina D, Iakovleva E, Roberts G, Chu DK, Peters RL, Du Toit G, Skypala I, Santos AFAllergy2023
  5. Boyano-martínez T, García-ara C, Díaz-pena J, Martín-esteban MThe Journal of Allergy and Clinical Immunology2002